Today, Catawba Research is in a state of planned growth having established itself as a go-to CRO for an array indications.
The truth of the matter is Catawba Research is the place our President & CEO, Zaidoon A. Al-Zubaidy, always wanted to work. With nearly 30 years of experience on the Sponsor side of the clinical trial table, Zaidoon set out to create a working environment where people could do the work they love, but also be valued for their contributions. If you visit our office, what you will feel is Catawba Research is a place that cares about people—from our staff to the patients in our trials to the patients needing the treatments being tested—we care about people. What is clear is we cannot do what we do without positive leadership and a team of experts at the ready to take on the challenges of clinical trials.
Catawba Research is a trusted research organization defined by its nimble approach to study design and execution. Boasting over 100 years of C-suite experience and an expansive and evolving portfolio of therapeutic success, we help set the standard for CRO leadership. With consistent scientific engagement and targeted fiscal responsibility, we set ourselves apart from the competition. We believe quality is found in the details, and our precision focus on timelines and cost-conscious design allows us to deliver the right results at the right time — for the right price. In fact, while only 20% of clinical trials finish on time, 70% of all clinical trials partnered with Catawba Research either meet or exceed their timeline objectives.
Catawba utilizes dedicated international management teams and executive-level oversight to guarantee protocol compliance and keep every component of a project on track. What’s more, our “Always Audit Ready” TMF documentation guarantees you are prepared to confidently overcome any regulatory obstacle and push your project forward without delay. This proactive approach has awarded us over 30 regulatory approvals — the most achieved without a single change order. On top of that, our therapeutic portfolio is growing rapidly, as we leverage our impressive track record in dermatology and women’s health into more recent triumphs in pulmonary, autoimmune and neurology research.
Despite this growing success as a global CRO, Catawba retains an agile approach to study delivery and assigns active roles to its executives. With a fixed-budget mentality, innovative trial management and robust quality assurance, Catawba is a full-service CRO with a passion for people — those patients in need of treatment and those professionals looking to unlock new possibilities in health care.
